Arslan Ardicoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arslan Ardicoglu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Ali Fuat Atmaca
Department of Urology, School of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkiye
7 shared publications - Abdullah Erdem Canda
KOÇ ÜNİVERSİTESİ, TIP FAKÜLTESİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, ÜROLOJİ ANABİLİM DALI
5 shared publications - Bahri Gok
Department of Urology School of Medicine affiliated with Ankara City Hospital Ankara Yildirim Beyazit University Ankara Turkey
3 shared publications - Murat Keske
Kayseri City Hosp, Clin Urol, Kayseri, Turkey
3 shared publications - Davut Kamaci
Ankara City Hosp, Dept Urol, Ankara, Turkey
2 shared publications - Erem Asil
Department of Urology Ankara City Hospital Ankara Turkey
2 shared publications
Latest Publications
- Open Access
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1373-1379
Prone versus Barts “flank-free” modified supine percutaneous nephrolithotomy: a match-pair analysis
Background/aim: In this study, we aimed to compare the results of prone and Barts "flank-free" modified supine percutaneous nephrolithotomy (PCNL) operations in our clinic. Materials and methods: The data from patients that underwent Barts "flank-free" modified supine PCNL (BS-PCNL) (n = 52) between June 2018 and July 2020 and prone PCNL (P-PCNL) (n = 286) between April 2014 and June 2018 were retrospectively evaluated. Of those 286 patients, 104 patients whose sex, age, body mass index, American Society of Anesthesiology score, stone localization, stone size, and hydronephrosis matched the BS-PCNL group in a 1:2 ratio were included in the study. The groups were compared in terms of intraoperative outcome, complication rates, and stone-free rates. Results: The mean age of all patients (58 females, 98 males) included in the study was 41.8 +/- 15.2 years, and the mean body mass index (BMI) was 24.7 +/- 2.9 kg/m(2). The mean operation time was significantly shorter in the BS-PCNL group than in the P-PCNL group (80.2 +/- 15.1 min vs. 92.4 +/- 22.7 min and p = 0.01). There was no significant difference between the two groups in terms of fluoroscopy time, intraoperative complications, postoperative complications, and stone-free rates. Conclusion: Our study shows that BS-PCNL is an effective and safe method that significantly reduces the operation time and should be considered as one of the primary treatment options for patients scheduled for PCNL.
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1373-1379
Open AccessProne versus Barts “flank-free” modified supine percutaneous nephrolithotomy: a match-pair analysis
Background/aim: In this study, we aimed to compare the results of prone and Barts "flank-free" modified supine percutaneous nephrolithotomy (PCNL) operations in our clinic. Materials and methods: The data from patients that underwent Barts "flank-free" modified supine PCNL (BS-PCNL) (n = 52) between June 2018 and July 2020 and prone PCNL (P-PCNL) (n = 286) between April 2014 and June 2018 were retrospectively evaluated. Of those 286 patients, 104 patients whose sex, age, body mass index, American Society of Anesthesiology score, stone localization, stone size, and hydronephrosis matched the BS-PCNL group in a 1:2 ratio were included in the study. The groups were compared in terms of intraoperative outcome, complication rates, and stone-free rates. Results: The mean age of all patients (58 females, 98 males) included in the study was 41.8 +/- 15.2 years, and the mean body mass index (BMI) was 24.7 +/- 2.9 kg/m(2). The mean operation time was significantly shorter in the BS-PCNL group than in the P-PCNL group (80.2 +/- 15.1 min vs. 92.4 +/- 22.7 min and p = 0.01). There was no significant difference between the two groups in terms of fluoroscopy time, intraoperative complications, postoperative complications, and stone-free rates. Conclusion: Our study shows that BS-PCNL is an effective and safe method that significantly reduces the operation time and should be considered as one of the primary treatment options for patients scheduled for PCNL.
- 5 January 2021
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 17 (3)
Outcomes and complications of radical cystectomy with ileal conduit urinary diversion: A comparison between open, semi‐robotic and totally robotic surgery
Background: It was aimed to compare open versus robotic‐assisted radical cystectomy (RARC) with intracorporeal ileal conduit (ICIC), versus RARC with extracorporeal ileal conduit (ECIC) formation for bladder cancer.Materials and Methods: Open, RARC‐ECIC and RARC‐ICIC groups were compared in terms of patient demographics, operative and postoperative parameters, pathological parameters, complications and functional outcomes.Results: Mean operative times were lower in the RARC‐ECIC group (p = 0.004). Mean estimated blood loss was significantly lower (p < 0.01) in the robotic groups. The blood transfusion was lower in RARC‐ICIC groups (p < 0.001). Rates of stage pT3–4 disease were the highest in the RARC‐ICIC group (p = 0.004). LOS was significantly shorter in the RARC‐ICIC group (p = 0.01). Numbers of Clavien 3–5 complications were lower in the robotic groups (p = 0.012).Conclusions: RARC and ICIC is a complex procedure involving an increased operation time but with the advantages of lower estimated blood loss, transfusion rates, complications and hospital stays compared with open surgery.
- 5 January 2021
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 17 (3)
Outcomes and complications of radical cystectomy with ileal conduit urinary diversion: A comparison between open, semi‐robotic and totally robotic surgery
Background: It was aimed to compare open versus robotic‐assisted radical cystectomy (RARC) with intracorporeal ileal conduit (ICIC), versus RARC with extracorporeal ileal conduit (ECIC) formation for bladder cancer.Materials and Methods: Open, RARC‐ECIC and RARC‐ICIC groups were compared in terms of patient demographics, operative and postoperative parameters, pathological parameters, complications and functional outcomes.Results: Mean operative times were lower in the RARC‐ECIC group (p = 0.004). Mean estimated blood loss was significantly lower (p < 0.01) in the robotic groups. The blood transfusion was lower in RARC‐ICIC groups (p < 0.001). Rates of stage pT3–4 disease were the highest in the RARC‐ICIC group (p = 0.004). LOS was significantly shorter in the RARC‐ICIC group (p = 0.01). Numbers of Clavien 3–5 complications were lower in the robotic groups (p = 0.012).Conclusions: RARC and ICIC is a complex procedure involving an increased operation time but with the advantages of lower estimated blood loss, transfusion rates, complications and hospital stays compared with open surgery.
- 28 July 2020
- Published by Hindawi Limited in Andrologia
- Vol. 52 (10) , e13770
Which is the best radiological imaging method for predicting actual prostate weight?
In this study, we compared the weight of the prostate specimen removed after robotic radical prostatectomy with the prostate weight measured pre‐operatively by four different imaging modalities. Pre‐operative prostate weight before robotic radical prostatectomy was measured by Transabdominal Ultrasonography (TAUS), Transrectal Ultrasonography (TRUS), Abdominal Tomography (CT) and MultiparametricProstate Magnetic Resonance imaging (mpMRI). Of the 170 patients enrolled in the study, the mean age was 65.2 ± 7.08 (46–84) years and mean prostate‐specific antigen (PSA) 9.6 ± 7.7 (1.8–50). The mean post‐operative actual prostate weight was 63.1 ± 30 gr. The mean pre‐operative prostate volumes measured by TAUS, TRUS, CT and MPMRI were 64.5 ± 28.5, 49.1 ± 30.6, 54.5 ± 30.5 and 68.7 ± 31.7 ml, respectively (p < .001). Post‐operative actual prostate weight correlated with prostate weight measured by TAUS, TRUS, CT and mpMRI (r coefficient 0.776, 0.802, 0.768 and 0.825 respectively). The best of these was mpMRI. Although prostate weight measured by different imaging methods has a high correlation to predict actual prostate weight, actual prostate weight is best predicted by measurements with mpMRI. However, errors and deviations that may occur with these imaging methods should be taken into consideration.
- 28 July 2020
- Published by Hindawi Limited in Andrologia
- Vol. 52 (10) , e13770
Which is the best radiological imaging method for predicting actual prostate weight?
In this study, we compared the weight of the prostate specimen removed after robotic radical prostatectomy with the prostate weight measured pre‐operatively by four different imaging modalities. Pre‐operative prostate weight before robotic radical prostatectomy was measured by Transabdominal Ultrasonography (TAUS), Transrectal Ultrasonography (TRUS), Abdominal Tomography (CT) and MultiparametricProstate Magnetic Resonance imaging (mpMRI). Of the 170 patients enrolled in the study, the mean age was 65.2 ± 7.08 (46–84) years and mean prostate‐specific antigen (PSA) 9.6 ± 7.7 (1.8–50). The mean post‐operative actual prostate weight was 63.1 ± 30 gr. The mean pre‐operative prostate volumes measured by TAUS, TRUS, CT and MPMRI were 64.5 ± 28.5, 49.1 ± 30.6, 54.5 ± 30.5 and 68.7 ± 31.7 ml, respectively (p < .001). Post‐operative actual prostate weight correlated with prostate weight measured by TAUS, TRUS, CT and mpMRI (r coefficient 0.776, 0.802, 0.768 and 0.825 respectively). The best of these was mpMRI. Although prostate weight measured by different imaging methods has a high correlation to predict actual prostate weight, actual prostate weight is best predicted by measurements with mpMRI. However, errors and deviations that may occur with these imaging methods should be taken into consideration.
- 1 January 2019
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 45 (1) , S42-S48
Does extent of prostate-specific antigen fluctuation can predict Gleason score upgrading in low-risk prostate cancer patients?
Objective: To evaluate the effect of prostate-specific antigen (PSA) fluctuation on Gleason score (GS) upgrading, disease upstaging, oncological outcomes in low-risk prostate cancer (PCa) patients who underwent robot-assisted laparoscopic radical prostatectomy (RARP) and met the inclusion criteria for active surveillance (AS). Material and methods: Data of 354 low-risk PCa patients who underwent RARP were retrospectively evaluated. Patients were divided into two groups: PSA fluctuation rate9.5%/month (Group 2, n=162). Mainly compared parameters were GS upgrading, disease upstaging, biochemical recurrence (BCR) and surgical margin positivity (SMP) rates. Results: GS upgrading, disease upstaging and SMP were detected in 128 (36.2%), 56 (15.8%) and 42 (11.9%) patients, respectively. After a median follow-up of 46 months, BCR was observed in 40 (11.3%) patients. GS upgrading (41.1% vs. 30.2%, p=0.033), disease upstaging (19.8% vs. 11.1%, p=0.028), SMP (15.1% vs. 8%, p=0.035) and BCR development (15.6% vs. 6.2%, p=0.005) rates were statistically significantly higher in Group 1 than Group 2. In multivariate analysis, digital rectal examination positivity, the presence of two positive cores and low PSA fluctuation rate were found to be significant predictors of GS upgrading. Conclusion: Low PSA fluctuation rate is associated with higher GS upgrading. Cite this article as: Hamidi N, Atmaca AF, Canda AE, Keske M, Ardıçoğlu A. Does extent of prostate-specific antigen fluctuation can predict Gleason score upgrading in low-risk prostate cancer patients? Turk J Urol 2019; 45(Supp. 1): S42-S48.
- 1 January 2019
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 45 (1) , S42-S48
Does extent of prostate-specific antigen fluctuation can predict Gleason score upgrading in low-risk prostate cancer patients?
Objective: To evaluate the effect of prostate-specific antigen (PSA) fluctuation on Gleason score (GS) upgrading, disease upstaging, oncological outcomes in low-risk prostate cancer (PCa) patients who underwent robot-assisted laparoscopic radical prostatectomy (RARP) and met the inclusion criteria for active surveillance (AS). Material and methods: Data of 354 low-risk PCa patients who underwent RARP were retrospectively evaluated. Patients were divided into two groups: PSA fluctuation rate9.5%/month (Group 2, n=162). Mainly compared parameters were GS upgrading, disease upstaging, biochemical recurrence (BCR) and surgical margin positivity (SMP) rates. Results: GS upgrading, disease upstaging and SMP were detected in 128 (36.2%), 56 (15.8%) and 42 (11.9%) patients, respectively. After a median follow-up of 46 months, BCR was observed in 40 (11.3%) patients. GS upgrading (41.1% vs. 30.2%, p=0.033), disease upstaging (19.8% vs. 11.1%, p=0.028), SMP (15.1% vs. 8%, p=0.035) and BCR development (15.6% vs. 6.2%, p=0.005) rates were statistically significantly higher in Group 1 than Group 2. In multivariate analysis, digital rectal examination positivity, the presence of two positive cores and low PSA fluctuation rate were found to be significant predictors of GS upgrading. Conclusion: Low PSA fluctuation rate is associated with higher GS upgrading. Cite this article as: Hamidi N, Atmaca AF, Canda AE, Keske M, Ardıçoğlu A. Does extent of prostate-specific antigen fluctuation can predict Gleason score upgrading in low-risk prostate cancer patients? Turk J Urol 2019; 45(Supp. 1): S42-S48.
- Open Access
- 25 August 2018
- Published by Springer Nature in Diagnostic Pathology
- Vol. 13 (1) , 60
Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression
Clear cell renal cell carcinoma (ccRCC) is the most common renal malignancy. Hypoxia-inducible factors, HIF-1α and HIF-2α, are expressed in the majority of ccRCC. Targeting immune checkpoints with the blockade of PD-1 and its ligand PD-L1 reorganizes T-cell activity in tumor microenvironment and provides important antitumor responses. PD-L1 upregulation has been found to be hypoxia-inducible factor (HIF) dependent. Our aim is to demonstrate the association between PD-L1 and HIF expression and to reveal the role of PD-L1 in prognosis and its association with tumor microenvironment. Surgical specimens from 145 patients diagnosed with ccRCC, who had undergone radical or partial nephrectomy, were retrospectively analyzed. Immunohistochemistry on tissue microarrays (TMA) was performed to demonstrate expressions of PD-L1, HIF-1α, and HIF-2α in tumor cells and PD-1, CD4, and CD8 in lymphocytes to assess lymphocyte density in tumor microenvironment. PD-L1 tumor cell expression was detected in 20/125 (13.8%) cases, which correlated with higher levels of PD-1, CD4, CD8 and HIF-2α expression. Low or high expression of HIF-1α was similar in PD-L1-positive cases. When PD-L1-positive cases were compared with negative ones, there was no significant difference in terms of prognostic factors. However, the number of WHO/ISUP grade 3–4 tumors was significantly higher in PD-L1-positive cases than in negative ones. PD-L1 tumor cell expression is strongly associated with increased HIF-2α expression and presence of dense lymphocytic infiltration in ccRCCs. Our findings confirm that PD-L1 positivity is associated with high ISUP nucleolar grade. The association between PD-L1, HIF, and lymphocyte density in tumor microenvironment must be clarified and especially taken into account in combination treatment.
- 25 August 2018
- Published by Springer Nature in Diagnostic Pathology
- Vol. 13 (1) , 60
Open AccessPrognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression
Clear cell renal cell carcinoma (ccRCC) is the most common renal malignancy. Hypoxia-inducible factors, HIF-1α and HIF-2α, are expressed in the majority of ccRCC. Targeting immune checkpoints with the blockade of PD-1 and its ligand PD-L1 reorganizes T-cell activity in tumor microenvironment and provides important antitumor responses. PD-L1 upregulation has been found to be hypoxia-inducible factor (HIF) dependent. Our aim is to demonstrate the association between PD-L1 and HIF expression and to reveal the role of PD-L1 in prognosis and its association with tumor microenvironment. Surgical specimens from 145 patients diagnosed with ccRCC, who had undergone radical or partial nephrectomy, were retrospectively analyzed. Immunohistochemistry on tissue microarrays (TMA) was performed to demonstrate expressions of PD-L1, HIF-1α, and HIF-2α in tumor cells and PD-1, CD4, and CD8 in lymphocytes to assess lymphocyte density in tumor microenvironment. PD-L1 tumor cell expression was detected in 20/125 (13.8%) cases, which correlated with higher levels of PD-1, CD4, CD8 and HIF-2α expression. Low or high expression of HIF-1α was similar in PD-L1-positive cases. When PD-L1-positive cases were compared with negative ones, there was no significant difference in terms of prognostic factors. However, the number of WHO/ISUP grade 3–4 tumors was significantly higher in PD-L1-positive cases than in negative ones. PD-L1 tumor cell expression is strongly associated with increased HIF-2α expression and presence of dense lymphocytic infiltration in ccRCCs. Our findings confirm that PD-L1 positivity is associated with high ISUP nucleolar grade. The association between PD-L1, HIF, and lymphocyte density in tumor microenvironment must be clarified and especially taken into account in combination treatment.
- 1 September 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (6) , e2428
Robotic radical prostatectomy as an initial treatment approach in men at high risk of disseminated prostate cancer: Experience in 8 patients
- 1 September 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (6) , e2428
Robotic radical prostatectomy as an initial treatment approach in men at high risk of disseminated prostate cancer: Experience in 8 patients
- 1 September 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (6) , e2455
Robot-assisted laparoscopic transperitonetal pyeloplasty: Surgical technique in the presence of crossing vessel
- 1 September 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (6) , e2455
Robot-assisted laparoscopic transperitonetal pyeloplasty: Surgical technique in the presence of crossing vessel
- 1 September 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (7) , 346
Concurrent robotic Trans-Abdominal Pre-Peritoneal (TAPP) inguinal herniorrhaphy during robotic-assisted radical prostatectomy
- 1 September 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (7) , 346
Concurrent robotic Trans-Abdominal Pre-Peritoneal (TAPP) inguinal herniorrhaphy during robotic-assisted radical prostatectomy